Higher-severity device and patient exposure

Implantable Medical Device Insurance

Implantable medical device risks can carry long-tail liability, severe patient injury, recall, field safety and regulatory exposure. The submission needs to explain the product, patient use, quality systems and downstream responsibility in more detail than an ordinary manufacturing case.

Review implantable device risk Speak to a specialist
Class III and invasive devices Patient injury severity Recall and long-tail liability

Specialist review before market approach

Implantable medical device insurance review for Class III, invasive, orthopaedic, prosthetic and specialist device businesses with patient injury, recall and long-tail liability exposure.

Insure24 can help prepare the underwriting story, but cover and terms always depend on the risk details, disclosure, wording, controls and available market appetite.

Who this helps

  • Class III, implantable, invasive and high-severity medical device businesses.
  • Orthopaedic, prosthetic, surgical, dental, cardiovascular or specialist device manufacturers.
  • Businesses with design, specification, testing, supply-chain or post-market surveillance responsibility.
  • Companies needing product liability, recall, PI, cyber, D&O or clinical-trial exposures reviewed together.

What markets usually need

  • Device class, clinical use, invasive or implantable nature and patient population.
  • Design responsibility, manufacturing route, supplier dependency, QA and testing.
  • Traceability, complaints, vigilance, recall procedures and post-market surveillance.
  • Territories, contracts, clinical evidence, prior incidents and required limits.

Market context

  • Implantable-device appetite depends heavily on device criticality, intended use, patient population and claims severity.
  • Markets usually need a clear story on design responsibility, quality controls, traceability and vigilance.
  • Recall, corrective action and field safety issues can be more severe where products are already implanted.

Why implantable devices need separate framing

The search intent is different from a general medical device page because severity and patient outcome drive market appetite.

  • A single defect can create long-tail injury exposure.
  • Recall and corrective action may be harder once products are implanted.
  • Clinical evidence and quality systems carry more weight in underwriting.

How this connects to the existing cluster

This page captures the buyer wording, then points into the detailed Class III and implantable manufacturing route.

  • Use the deeper page for manufacturing-specific detail.
  • Use clinical trials liability if participant exposure is immediate.
  • Use product recall or product liability pages where those covers are the main concern.

Related specialist routes

Class III and implantable devicesReview the related route before sending a complex commercial enquiry to market. Medical device product liability insuranceReview the related route before sending a complex commercial enquiry to market. Clinical trials liability insuranceReview the related route before sending a complex commercial enquiry to market. ATMP insuranceReview the related route before sending a complex commercial enquiry to market.

Implantable Medical Device Insurance FAQs

Is implantable device insurance hard to place?

It can be more specialist because patient injury, recall severity and long-tail liability are usually higher than for lower-risk devices.

Does Class III device insurance include recall?

Recall may need specific wording or a separate section. The right structure depends on the device, territory, policy and market appetite.

What documents help?

Product description, device class, intended use, clinical evidence, QA controls, traceability, contracts, territories and claims history are useful.

Send the risk for specialist review

Share the activity, cover needed, claims history, contract requirements and any previous market feedback so the enquiry can be triaged properly before approach.

Review implantable device risk